Communications regarding medical assistance in dying with respect to advance requests, the state of palliative care, and the protection of Canadians with disabilities. Law enforcement also includes Search and Rescue and dementia friendly communities. Canadian Institutes of Health Research (CIHR) - as it relates to increased federal funding and long-term investment in dementia research exceeding 1% of direct dementia care costs (aspirational goal in national dementia strategy). Support for health research infrastructure and continued CIHR partnerships with charitable non-profits like ASC. Budget 2025 - Canada Strong as as it relates to dementia and caregiving as national challenges that require coordinated action across governments and communities. Support for health data, AI, and innovation investments. Continued support for the National Dementia Strategy with targeted investments to reduce impact and costs associated with dementia care. Communications regarding the Canada Disability Benefit to ensure accessibility for individuals with cognitive impairment, including with Alzheimer's or other dementias. Create and fund programs to support Canadians diagnosed with young-onset dementia. Communications regarding the Canada Post strike and its adverse financial impacts (i.e. donations) on the charitable sector. Communications regarding potential funding to Alzheimer Society Research Program for research to study the topic of Veterans and Dementia in a truly Canadian context. Communications regarding the need for $20 million over 5 years through programs like Age Well at Home, and a longer-term and larger commitment to programs like ASC's FirstLink® that have been proven to support people with dementia to live well as long as possible at home and in the community. Communications regarding the need to invest $15 million over 3 years to implement national standards for diagnosis, treatment and care for Alzheimers disease and dementia. This will ensure that the health systems across the country have access to quality standards to be able to realize the benefits of any disease modifying drugs approved in Canada. Health Canada as it pertains to the approval of disease-modifying treatments for Alzheimer's disease and other dementias that aim to slow or halt the progression of the disease. National standards and Safe Long-term Care Act include a common standard for the definition of an Essential Care Partner (ECP). Improve access to palliative and end-of-life care for people living with dementia in Canada. Implementation metrics and success criteria for "A Dementia Strategy for Canada:Together We Aspire." Funding opportunities under PHAC's Dementia Community Investment and Dementia Strategic Fund to support awareness-raising, dementia guidelines, diversity & Inclusion and best practices.